Credophar SRL
The score of Credophar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +4 % Total assets -8 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Credophar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 30 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 25 Aug 2022
Credophar's financial analysis
- Solvency24.6%sector median: 45.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Credophar
Credophar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0849.730.193
- VAT number
- BE0849730193
- Peppol
- Registered · 0208:0849730193 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Oct 2012
- Registered office
- 9051 Ghent
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Credophar (SRL) has been based in Ghent since 2012, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 51,670 € and equity of €1.93m; its revenue is not published. Its solvency stands at 24.6%, below the median of its sector (45.8%).
Companies similar to Credophar
Companies in the same business, of comparable size and area, outside its group.
- Motion Medical Holding Manufacture of medical and dental instruments and supplies Les Bons Villers · balance sheet €4.44m
- Revvity Activities of agents involved in non-specialised wholesale Lier · balance sheet €6.18m
- Celyntra Therapeutics Wholesale of pharmaceutical and medical goods Mont-Saint-Guibert · balance sheet €8.20m
- ERC Pharma Wholesale of pharmaceutical and medical goods Gembloux · balance sheet €3.56m
- Biognost Wholesale of pharmaceutical and medical goods Kortrijk · balance sheet €7.26m
- Vetservices Wholesale of pharmaceutical and medical goods Kortemark · balance sheet €8.48m
- Etablissements Henri Nootens Wholesale of pharmaceutical and medical goods Schaerbeek · balance sheet €5.13m
- Contipharma Wholesale of pharmaceutical and medical goods Seraing · balance sheet €7.21m
Frequently asked questions about Credophar
What is the revenue of Credophar?
Credophar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Credophar?
In Belgium, the VAT number is the company number prefixed with BE: BE0849730193 for Credophar, if the company is VAT-registered. Its company number (CBE) is 0849.730.193.
Where is the registered office of Credophar?
According to the CBE register, the registered office of Credophar is in 9051 Ghent.
What is the equity of Credophar?
At the close of the 2025 financial year, the equity of Credophar amounts to 1,930,520 €, a solvency of 24.6% of total assets.
Who manages Credophar?
The register lists 4 active mandates at Credophar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Credophar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →